LIVE STREAM: NYSE CRTR Economy Event Watch now →

Advertisement
Advertisement

BMEDvsXLVETF Comparison

ETF 1
BMED

iShares Health Innovation Active ETF

This fund is part of
Healthcare Technology
-0.02%
VS
ETF 2
XLV

State Street Health Care Select Sector SPDR ETF

This fund is part of
US Health Care
+0.28%

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. State Street Health Care Select Sector SPDR ETF (XLV) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.08% for XLV. BMED is down -7.1% year-to-date (YTD) with +$4M in YTD flows. XLV performs better with -5.73% YTD performance, and +$459M in YTD flows. Run a side-by-side ETF comparison of BMED and XLV below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BMED vs XLV performance and flow charts

Performance

-4.0-3.0-2.0-1.00.01.02.03.0%Apr 6Apr 13Apr 20Apr 27May 4

Cumulative Flows

-600 M-400 M-200 M0 M200 MApr 6Apr 13Apr 20Apr 27May 4

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 05/05/2026
1M3MYTD1Y3Y5Y
Perf.
BMED
XLV
-2.05%-0.65%
-7.29%-5.82%
-7.10%-5.73%
+15.51%+7.13%
+14.75%+14.32%
-1.63%+28.00%
Flows
BMED
XLV
--$655M
+$1M-$1.12B
+$4M+$459M
+$7M-$90M
+$4M-$5.73B
+$5M+$6.41B
Volatility and drawdown
3M1Y3Y5Y
Volatility
BMED
XLV
+16.78%+15.29%
+15.52%+15.64%
+15.60%+13.74%
+17.55%+14.61%
Max drawdown
BMED
XLV
-10.97%-10.51%
-13.52%-10.51%
-19.76%-17.05%
-33.96%-17.05%
Max drawdown duration
BMED
XLV
65d65d
103d65d
237d444d
1586d444d
Trading data

Create an account to view trading data

Join for free
BMED
XLV
Last sale
5/5/2026 at 1:30 PM
$28.13
$145.30
Previous close
05/05/2026
$27.84
$144.73
Consolidated volume
05/05/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of April 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

BMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
BMED
XLV
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 5/5/2026 at 1:30 PM
Live
Closed
BMED
XLV
Last price
$28.13
$145.30
1D performance
+1.03%
+0.39%
AuM$10.13 M$37.64 B
E/R0.77%0.08%
Characteristics
BMED
XLV
Management strategyActivePassive
ProvideriSharesState Street Investment Management
Benchmark-S&P Health Care Select Sector Index
N° of holdings3556
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 29, 2020December 16, 1998
ESGNoNo
Advertisement
Exposure

Countries

BMED
USA
91.63%
Other
8.37%
XLV
USA
97.26%
Other
2.74%

Sectors

BMED
Health Care
85.5%
Other
14.5%
XLV
Health Care
98.29%
Other
1.71%
Advertisement

Diversification

BMED

Total weight of top 15 holdings out of 15

61.4%
XLV

Total weight of top 15 holdings out of 15

70.96%

Top 15 holdings

Data as of March 31, 2026
BMED
JOHNSON&JOHNSON
7.99%
US0669224778
7.13%
MERCK & CO INC
5.59%
GILEAD SCIENCES
5.48%
AMGEN-T
4.46%
EDWARDS LIFESCIENCES
4.33%
BIOGEN INC
3.36%
GUARDANT HEALTH INC
3.04%
WUXI BIOLOGICS (CAYMAN)
3.02%
METTLER TOLEDO
2.93%
VERTEX PHARMACEUTICALS
2.92%
WATERS
2.92%
CHRLS RIVER LABS
2.91%
MODERNA INC
2.79%
US04016X1019
2.54%
XLV
LILLY
13.74%
JOHNSON&JOHNSON
11.10%
ABBVIE
7.25%
MERCK & CO INC
5.63%
UNITEDHEALTH GRP
4.62%
AMGEN-T
3.57%
THERMO FISHER SCIENTIFIC
3.48%
ABBOTT LABS
3.37%
GILEAD SCIENCES
3.26%
INTUITIVE SURGICAL
3.09%
PFIZER
3.01%
BRISTOL-MYERS SQUIBB
2.33%
DANAHER
2.25%
VERTEX PHARMACEUTICALS
2.14%
STRYKER
2.13%
Frequently asked questions about BMED and XLV

How have the BMED and XLV ETFs performed in 2026?

As of May 5, 2026, BMED is down -7.1% year-to-date (YTD), while XLV has lost -5.73%. That puts XLV better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or XLV?

Year-to-date, the BMED ETF saw +$4M in flows, compared to +$459M for XLV.

Which ETF is more volatile: BMED or XLV?

Over the past year, BMED had a volatility of 15.52%, while XLV experienced 15.64%.

Which ETF is bigger: BMED or XLV?

As of May 5, 2026, BMED holds $10.13 M in assets under management (AUM), while XLV manages $37.64 B.

What sectors do the BMED and XLV ETFs invest in?

BMED leans toward sectors like Health Care. Meanwhile, XLV focuses on Health Care.

What are the top holdings of the BMED ETF and XLV ETF?

BMED top holdings include JOHNSON&JOHNSON, US0669224778 and MERCK & CO INC. XLV holds in its top three: LILLY, JOHNSON&JOHNSON and ABBVIE.

Which ETF is more diversified: BMED or XLV?

BMED holds 48 securities with 61.4% of its assets in the top 15. XLV has 59 securities and a top 15 weight of 70.96%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up